Trial

Ed Brabant
Ed Brabant Member Posts: 61

Just got the news that I start the clinica trial at MGH 4/6/17 with Varliumab and Nivoulmab. Every other Thursday. Looking forward to starting this journey. 

Comments

  • foxhd
    foxhd Member Posts: 3,181 Member
    Good luck Ed

    A clinical trial of MDX 1106 saved my life in 2011. Now it is called nivolumab. It makes me proud to think my participation and success has helped to save many other lives.

  • rhominator
    rhominator Member Posts: 233 Member
    Great news

    That's great Ed. Look's like we're on the same schedule, albiet I'm not getting Varliumab.

  • pamstayner
    pamstayner Member Posts: 111 Member
    Do you know the trial number?

    I don't know what MGH stands for.  When I put the Varliumab and Nivoulmab words in the trail search field on Smart Patients, I could not find it. 

    Could you give me more info on this trial?

     

  • Abunai
    Abunai Member Posts: 173 Member
    edited April 2017 #5
    Another trial

    Good luck, Ed. I'm about three weeks in to a clinical trial with Nivolumab and CB-839. Hoping for the best for all of us.

  • Ed Brabant
    Ed Brabant Member Posts: 61

    Do you know the trial number?

    I don't know what MGH stands for.  When I put the Varliumab and Nivoulmab words in the trail search field on Smart Patients, I could not find it. 

    Could you give me more info on this trial?

     

    Mass General Hospital.

    Mass General Hospital.

  • Ed Brabant
    Ed Brabant Member Posts: 61

    Do you know the trial number?

    I don't know what MGH stands for.  When I put the Varliumab and Nivoulmab words in the trail search field on Smart Patients, I could not find it. 

    Could you give me more info on this trial?

     

    Trial

    I think this is the one. Mine has spread to my lungs.

    https://www.clinicaltrials.gov/ct2/show/NCT02659059?term=NCT02659059&rank=1

     

     

     

     

  • Ed Brabant
    Ed Brabant Member Posts: 61

    Trial

    I think this is the one. Mine has spread to my lungs.

    https://www.clinicaltrials.gov/ct2/show/NCT02659059?term=NCT02659059&rank=1

     

     

     

     

    Trial

    Just requested the number from Mass General. Bit of a hiccup. Biopsy tissue sample is too small. Waiting for a plan of action. Might be able to use the tissue from 2011 when I had my right kidney removed. Hope to hear by Thursday.

  • Ed Brabant
    Ed Brabant Member Posts: 61

    Trial

    Just requested the number from Mass General. Bit of a hiccup. Biopsy tissue sample is too small. Waiting for a plan of action. Might be able to use the tissue from 2011 when I had my right kidney removed. Hope to hear by Thursday.

    Trial Info

     16-217:

     

    Protocol Title: A Phase I/II, Dose-Escalation and Cohort Expansion Study of the

    Safety, Tolerability and Efficacy of Anti-CD27 Antibody (Varlilumab) Administered

    in Combination with Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors

    (cdx1127-02)

    Sponsor Protocol Number: CDX1127-02

  • Ed Brabant
    Ed Brabant Member Posts: 61

    Do you know the trial number?

    I don't know what MGH stands for.  When I put the Varliumab and Nivoulmab words in the trail search field on Smart Patients, I could not find it. 

    Could you give me more info on this trial?

     

    Trial Info

     16-217:

     

    Protocol Title: A Phase I/II, Dose-Escalation and Cohort Expansion Study of the

    Safety, Tolerability and Efficacy of Anti-CD27 Antibody (Varlilumab) Administered

    in Combination with Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors

    (cdx1127-02)

    Sponsor Protocol Number: CDX1127-02

  • Ed Brabant
    Ed Brabant Member Posts: 61
    edited April 2017 #11

    Do you know the trial number?

    I don't know what MGH stands for.  When I put the Varliumab and Nivoulmab words in the trail search field on Smart Patients, I could not find it. 

    Could you give me more info on this trial?

     

    Trial #

    Here is the trial.

     

    http://www.dfhcc.harvard.edu/research/research-programs/discipline-based-programs/cancer-immunology/clinical-trials/